This is a demo store. No orders will be fulfilled.

Dehydroevodiamine - 98%, high purity , CAS No.67909-49-3

    Grade & Purity:
  • ≥98%
In stock
Item Number
D413067
Grouped product items
SKU Size
Availability
Price Qty
D413067-5mg
5mg
3
$9.90
D413067-25mg
25mg
3
$36.90
D413067-100mg
100mg
3
$122.90

COX-2 Selective Inhibitors

Basic Description

Synonyms Indolo[2',3':3,4]pyrido[2,1-b]quinazolinium, 5,7,8,13-tetrahydro-14-methyl-5-oxo-, inner salt | AKOS016010126 | BS-17904 | GLXC-14697 | 8NT3HW64V9 | A867162 | 14-Methyl-5-oxo-7,8-dihydro-5H-indolo[2',3':3,4]-pyrido[2,1-b]quinazolin-14-ium-13-ide | 14-Meth
Specifications & Purity ≥98%
Biochemical and Physiological Mechanisms Dehydroevodiamine (DHED), a constituent of Evodia rutaecarpa, has various biological effects such as hypotensive, negative chronotropic, ion channel depressant, inhibition of nitric oxide production and cerebral blood flow enhancing activities. Dehydroevo
Storage Temp Store at -20°C
Shipped In
Ice chest + Ice pads
This product requires cold chain shipping. Ground and other economy services are not available.
Product Description

Information

Dehydroevodiamine (DHED), a constituent of Evodia rutaecarpa, has various biological effects such as hypotensive, negative chronotropic, ion channel depressant, inhibition of nitric oxide production and cerebral blood flow enhancing activities. Dehydroevodiamine inhibits LPS-induced iNOS, COX-2, prostaglandin E2 (PGE2) and nuclear factor-kappa B (NF-κB) expression in murine macrophage cells.


Targets

NF-κB ; COX-2 ; iNOS ; PGE2


In vivo

The dose ranging study demonstrated that the volume of distribution and clearance are independent of the dose. The primary route of elimination for the drug is via metabolism. i.v. administration of dehydroevodiamine elicited a slight but significant reduction in blood pressure and a marked decrease in heart rate.


Cell Research(from reference)

Cell lines:Cerebellar granule cells 

Concentrations:1-20 μM 

Incubation Time:9 days 


Product Describtion:

Dehydroevodiamine (DHED), a constituent of Evodia rutaecarpa, has various biological effects such as hypotensive, negative chronotropic, ion channel depressant, inhibition of nitric oxide production and cerebral blood flow enhancing activities. Dehydroevodiamine inhibits LPS-induced iNOS, COX-2, prostaglandin E2 (PGE2) and nuclear factor-kappa B (NF-κB) expression in murine macrophage cells.

Taxonomic Classification

Taxonomy Tree

Kingdom Organic compounds
Superclass Organoheterocyclic compounds
Class Diazanaphthalenes
Subclass Benzodiazines
Intermediate Tree Nodes Not available
Direct Parent Quinazolines
Alternative Parents Indoles and derivatives  Tetrahydropyridines  Benzenoids  Vinylogous amides  Tertiary carboxylic acid amides  Lactams  Azacyclic compounds  Organooxygen compounds  Organic oxides  Hydrocarbon derivatives  Amines  
Molecular Framework Aromatic heteropolycyclic compounds
Substituents Quinazoline - Indole or derivatives - Tetrahydropyridine - Benzenoid - Tertiary carboxylic acid amide - Vinylogous amide - Lactam - Carboxamide group - Carboxylic acid derivative - Azacycle - Hydrocarbon derivative - Organic oxide - Amine - Organic oxygen compound - Organooxygen compound - Organonitrogen compound - Organic nitrogen compound - Aromatic heteropolycyclic compound
Description This compound belongs to the class of organic compounds known as quinazolines. These are compounds containing a quinazoline moiety, which is made up of two fused six-member aromatic rings, a benzene ring and a pyrimidine ring.
External Descriptors Not available

Names and Identifiers

Pubchem Sid 504764903
Pubchem Sid Url https://pubchem.ncbi.nlm.nih.gov/substance/504764903
IUPAC Name 21-methyl-3,13,21-triazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1,3,5,7,9,15,17,19-octaen-14-one
INCHI InChI=1S/C19H15N3O/c1-21-16-9-5-3-7-14(16)19(23)22-11-10-13-12-6-2-4-8-15(12)20-17(13)18(21)22/h2-9H,10-11H2,1H3
InChIKey VXHNSVKJHXSKKM-UHFFFAOYSA-N
Smiles CN1C2=CC=CC=C2C(=O)N3C1=C4C(=C5C=CC=CC5=N4)CC3
Isomeric SMILES CN1C2=CC=CC=C2C(=O)N3C1=C4C(=C5C=CC=CC5=N4)CC3
Molecular Weight 301.35
Reaxy-Rn 624953
Reaxys-RN_link_address https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=624953&ln=

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

3 results found

Lot Number Certificate Type Date Item
B2313122 Certificate of Analysis Nov 04, 2022 D413067
B2313125 Certificate of Analysis Nov 04, 2022 D413067
B2313123 Certificate of Analysis Nov 04, 2022 D413067

Chemical and Physical Properties

Solubility Solubility (25°C) In vitro DMSO: 19 mg/mL (63.05 mM);    
Molecular Weight 301.300 g/mol
XLogP3 2.100
Hydrogen Bond Donor Count 0
Hydrogen Bond Acceptor Count 3
Rotatable Bond Count 0
Exact Mass 301.122 Da
Monoisotopic Mass 301.122 Da
Topological Polar Surface Area 35.900 Ų
Heavy Atom Count 23
Formal Charge 0
Complexity 753.000
Isotope Atom Count 0
Defined Atom Stereocenter Count 0
Undefined Atom Stereocenter Count 0
Defined Bond Stereocenter Count 0
Undefined Bond Stereocenter Count 0
The total count of all stereochemical bonds 0
Covalently-Bonded Unit Count 1

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.